Détention brevets de la classe C07D 215/58

Brevets de cette classe: 98

Historique des publications depuis 10 ans

8
9
6
8
7
7
10
3
4
2
2017 2018 2019 2020 2021 2022 2023 2024 2025 2026

Propriétaires principaux

Proprétaire
Total
Cette classe
Zydus Lifesciences Limited
141
10
Stemsynergy Therapeutics, Inc.
21
6
Bristol-myers Squibb Company
4747
4
The Regents of the University of Michigan
5063
4
Merck Sharp & Dohme LLC
3734
4
Cadila Healthcare Limited
286
3
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
787
3
Lycera Corporation
31
3
Pfizer Inc.
3423
2
FUJIFILM Corporation
30808
2
Northwestern University
3586
2
Korea Research Institute of Chemical Technology
1493
2
National Cancer Center
342
2
Ono Pharmaceutical Co., Ltd.
420
2
Shanghai Institute of Materia Medica, Chinese Academy of Sciences
880
2
The United States of America, as represented by the Secretary, Department of Health and Human Services
3024
2
Nanjing Gear Pharma & Tech Co., Ltd.
3
2
Prepaire Labs Limited
5
2
University of Hong Kong Versitech Limited
66
2
F. Hoffmann-La Roche AG
7795
1
Autres propriétaires 38